For those in the healthcare industry, telemedicine has been viewed as a way to increase access to healthcare, while mitigating the challenges of limited resources of physicians and healthcare providers. Although the use of telehealth has steadily grown over the past two decades, the challenges presented by the COVID-19 pandemic supercharged this growth. As the United States and the world move beyond the worst months and years of the pandemic, telemedicine usage will continue to change within the industry. This article from VMG Health explores the state of telehealth immediately prior to and during the early years of the pandemic to provide context for the question, “What will be the next stage of telemedicine in the U.S. healthcare system?” Read more.
Related Posts
How Thurston Group is Impacting the DSO Space
The company closed 65 deals in the dental and healthcare space in the first half of 2022.
October 12, 2023
How CMS Ownership-Transparency Rules Could Impact Home Health Dealmaking
The changes could also have an effect on the way buyers and sellers navigate M&A in the home health space – particularly those with less experience.
May 2, 2023
Cross-Market Health System Mergers are Becoming the Norm
The FTC is still wary of the anticompetition effects that may arise with cross-market merging.
July 13, 2022
Why Home Health Payment Uncertainty Could Lead to More Strategic M&A
It seems most are expecting the worse – yet another payment rate cut from the Centers for Medicare & Medicaid Services.
May 16, 2023